VX-561

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-561, covering 2022-01-25 to 2022-01-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis [Phase 2]

See pricing